Browsing the "Sofinnova Ventures" Tag →

30 2015 April
By FinSMEs
0 Comments

Mirna Therapeutics Completes $41.8M Series D Financing

Mirna Therapeutics, an Austin, TX-based clinical-stage biopharmaceutical and immuno-oncology company focused on the development of microRNA-based cancer therapeutics, completed a...

Read More →
09 2015 April
By FinSMEs
0 Comments

Edge Therapeutics Raises $72.5M in Funding

Edge Therapeutics, a Berkeley Heights, N.J.-based clinical-stage biotechnology company, raised approximately $72.5m in funding. The proceeds came from two private financing...

Read More →
06 2015 April
By FinSMEs
0 Comments

Natera Raises $55.5M

Natera, Inc., a San Carlos, Calif.-based genetic testing company, raised approximately $55.5m in funding. The round was led by Sofinnova...

Read More →
01 2015 April
By FinSMEs
0 Comments

aTyr Pharma Completes $76M Series E Financing

aTyr Pharma, Inc., a San Diego, CA-based biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address...

Read More →
27 2015 February
By FinSMEs
0 Comments

Chiasma Closes $70M Series E Financing Round

Chiasma, Inc., a U.S. privately-held biopharma company, closed a $70m Series E financing round. Backers included new investors Rock Springs...

Read More →
02 2014 December
By FinSMEs
0 Comments

Audentes Therapeutics Closes $42.5M Series B Financing

Audentes Therapeutics, Inc., a San Francisco, CA-based biotechnology company committed to the development and commercialization of gene therapy products for...

Read More →
01 2014 December
By FinSMEs
0 Comments

Ascendis Pharma Completes $60M Series D Financing

Ascendis Pharma A/S, a Hellerup, Denmark- Palo Alto, California- and Heidelberg, Germany-based biotechnology company, completed a $60m Series D financing....

Read More →
02 2014 October
By FinSMEs
0 Comments

Aclaris Therapeutics Closes $21M Series B Financing

Aclaris Therapeutics, Inc., a Malvern, Pennsylvania-based specialty pharmaceutical company, closed on a $21m Series B financing. Backers included existing investors...

Read More →
26 2014 August
By FinSMEs
0 Comments

Civitas Therapeutics Completes $55M Series C Financing

Civitas Therapeutics, Inc., a Chelsea MA-based biopharmaceutical company developing and commercializing therapeutics using its proprietary technology, completed a $55m Series...

Read More →
21 2014 August
By FinSMEs
0 Comments

Guavus Raises $20M in Funding

Guavus Inc., a San Mateo, CA-based provider of big data analytics solutions for operational intelligence, raised $20m in funding. Backers...

Read More →
23 2014 July
By FinSMEs
0 Comments

Sofinnova Ventures Closes Ninth Fund at $500M

Sofinnova Ventures, a Menlo Park based investment firm dedicated to life science, closed its ninth fund at $500m. Led by...

Read More →
27 2014 May
By FinSMEs
0 Comments

Spark Therapeutics Completes $72.8M Series B Financing

Spark Therapeutics, a Philadelphia, PA-based late-stage company developing gene-based medicines for a wide range of rare, debilitating diseases, completed a...

Read More →
19 2014 May
By FinSMEs
0 Comments

Coherus BioSciences Closes $55M Series C Financing

Coherus BioSciences, Inc., a San Francisco, CA-based biologics platform company focused on biosimilars, closed a $55m Series C financing. New...

Read More →
15 2014 May
By FinSMEs
0 Comments

Sorbent Therapeutics Closes $6.5M Tranche in $15M Series D Financing

Sorbent Therapeutics, Inc., a Sunnyvale, California-based biopharmaceutical company developing therapies for cardiovascular and renal diseases, closed a $6.5m tranche in...

Read More →